Legal entity
Last mentioned: 5d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
ip-patent is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Dr. Manlio Vinciguerra, the most common co-covered peer. The tracked stories average 2 original sources each. Dr. Eric Leire appears in 1 tracked Legal story from August 8, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 10 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Dr. Eric Leire. Shared-story counts are live from our verified record — not editorial picks.
Genflow Announces Patent Progress
Genflow Biosciences issues a regulatory news release disclosing the USPTO publication and outlining its layered patent strategy across four families.
USPTO Publishes SIRT6 Patent Application
Patent application US 2026/0199524 A1, covering the SIRT6 variant for NAFLD/NASH, is published, initiating the examination process.
Genflow Biosciences' US patent publication marks a pivotal step in its layered IP strategy for the SIRT6 variant, with four patent families covering composition, delivery, and therapeutic indications, highlighting the company's defensive approach in longevity biotech.
Dr. Eric Leire is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
